glutathione and multiple myeloma Lipid metabolic vulnerabilities of | Clinical Experimental Medicine The glutathione synthesis inhibitor buthionine
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega A myeloma targeting monoclonal antibody offers new hope for treating multiple myeloma EurekAlert! Pathogenesis and treatment of multiple myeloma PMC
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



